Source:http://linkedlifedata.com/resource/pubmed/id/16088802
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2005-8-9
|
pubmed:abstractText |
The need for a rotavirus vaccine in India is based on the enormous burden associated with the >100,000 deaths due to rotavirus diarrhea that occur annually among Indian children. Two rotavirus strains identified during nosocomial outbreaks of rotavirus infection in New Delhi and Bangalore, India, more than a decade ago are being developed as live oral vaccines. Infected newborns had no symptoms, shed virus for up to 2 weeks after infection, mounted a robust immune response, and demonstrated protection against severe rotavirus diarrhea after reinfection. The 2 strains are naturally occurring bovine-human reassortants. The New Delhi strain, 116E, is characterized as having a P[11],G9 genotype, and the Bangalore strain, I321, is characterized as having a P[11],G10 genotype. The strains have been prepared as pilot lots for clinical trials to be conducted in New Delhi. This unique project, which is developing a new rotavirus vaccine in India with the use of Indian strains, an Indian manufacturer, and an Indian clinical development program, aims to expedite introduction of rotavirus vaccines in India.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1899
|
pubmed:author |
pubmed-author:BahlRajivR,
pubmed-author:BernsteinDavid IDI,
pubmed-author:BhanMaharaj KMK,
pubmed-author:BhandariNitaN,
pubmed-author:GentschJon RJR,
pubmed-author:GlassRoger IRI,
pubmed-author:GreenbergHarryH,
pubmed-author:MaldonadoYvonneY,
pubmed-author:ParasharUmesh DUD,
pubmed-author:RaoC DurgaCD,
pubmed-author:RayPratimaP,
pubmed-author:WardRichard LRL
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
192 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S30-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16088802-Administration, Oral,
pubmed-meshheading:16088802-Clinical Trials as Topic,
pubmed-meshheading:16088802-Diarrhea,
pubmed-meshheading:16088802-Disease Outbreaks,
pubmed-meshheading:16088802-Genes, Viral,
pubmed-meshheading:16088802-Humans,
pubmed-meshheading:16088802-India,
pubmed-meshheading:16088802-Infant, Newborn,
pubmed-meshheading:16088802-Reassortant Viruses,
pubmed-meshheading:16088802-Rotavirus,
pubmed-meshheading:16088802-Rotavirus Infections,
pubmed-meshheading:16088802-Rotavirus Vaccines,
pubmed-meshheading:16088802-Vaccination,
pubmed-meshheading:16088802-Vaccines, Attenuated
|
pubmed:year |
2005
|
pubmed:articleTitle |
Development of candidate rotavirus vaccines derived from neonatal strains in India.
|
pubmed:affiliation |
Respiratory and Enteric Viruses Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. rglass@cdc.gov
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|